K Koli

865 total citations
13 papers, 701 citations indexed

About

K Koli is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K Koli has authored 13 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K Koli's work include TGF-β signaling in diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Medical Imaging and Pathology Studies (3 papers). K Koli is often cited by papers focused on TGF-β signaling in diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Medical Imaging and Pathology Studies (3 papers). K Koli collaborates with scholars based in Finland, United States and Switzerland. K Koli's co-authors include Jorma Keski‐Oja, Jussi Taipale, Carlos L. Arteaga, Robert Clarke, Teresa C. Dugger, Suvi‐Katri Leivonen, Veli‐Matti Kähäri, Risto Ala‐aho, Reidar Grénman and Juha Peltonen and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

K Koli

12 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Koli Finland 11 349 160 157 151 138 13 701
Laurence Vindevoghel United States 8 536 1.5× 108 0.7× 126 0.8× 76 0.5× 92 0.7× 10 775
Yasutaka Hayashido Japan 17 344 1.0× 269 1.7× 164 1.0× 65 0.4× 123 0.9× 47 780
Anne-Christine Poncelet United States 10 790 2.3× 103 0.6× 114 0.7× 85 0.6× 88 0.6× 10 1.1k
A Ohtsuru Japan 19 502 1.4× 272 1.7× 108 0.7× 122 0.8× 96 0.7× 30 862
Karolina Przybyłowska Poland 17 379 1.1× 241 1.5× 303 1.9× 103 0.7× 74 0.5× 48 828
Kelly J. Gordon United States 7 701 2.0× 315 2.0× 156 1.0× 79 0.5× 61 0.4× 10 1.0k
William A. May United States 12 662 1.9× 267 1.7× 161 1.0× 171 1.1× 93 0.7× 17 1.0k
K. W. Schmid Germany 17 219 0.6× 159 1.0× 135 0.9× 51 0.3× 47 0.3× 37 816
Shanna A. Arnold United States 12 228 0.7× 334 2.1× 143 0.9× 107 0.7× 44 0.3× 18 773
Óscar Busnadiego Spain 12 309 0.9× 73 0.5× 102 0.6× 105 0.7× 66 0.5× 12 761

Countries citing papers authored by K Koli

Since Specialization
Citations

This map shows the geographic impact of K Koli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Koli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Koli more than expected).

Fields of papers citing papers by K Koli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Koli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Koli. The network helps show where K Koli may publish in the future.

Co-authorship network of co-authors of K Koli

This figure shows the co-authorship network connecting the top 25 collaborators of K Koli. A scholar is included among the top collaborators of K Koli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Koli. K Koli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Syrjä, Pernilla, Eva Sutinen, Mari Palviainen, et al.. (2014). Upregulation of Alveolar Levels of Activin B, but not Activin A, in Lungs of West Highland White Terriers with Idiopathic Pulmonary Fibrosis and Diffuse Alveolar Damage. Journal of Comparative Pathology. 152(2-3). 192–200. 8 indexed citations
3.
Syrjä, Pernilla, Eva Sutinen, Mikko Rönty, et al.. (2013). Comparative Study of Transforming Growth Factor-β Signalling and Regulatory Molecules in Human and Canine Idiopathic Pulmonary Fibrosis. Journal of Comparative Pathology. 150(4). 399–407. 18 indexed citations
4.
Rönty, Mikko, Alexander P. Wohl, Sakari Joenväärä, et al.. (2013). Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug. Oncogenesis. 2(8). e66–e66. 36 indexed citations
5.
Keski‐Oja, Jorma, et al.. (2008). Fibronectin and heparin binding domains of latent TGF-β binding protein (LTBP)-4 mediate matrix targeting and cell adhesion. Experimental Cell Research. 314(13). 2488–2500. 53 indexed citations
6.
Myllärniemi, Marjukka, Kirsi Vuorinen, Ville Pulkkinen, et al.. (2007). Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. The Journal of Pathology. 214(4). 456–463. 35 indexed citations
7.
Leivonen, Suvi‐Katri, Risto Ala‐aho, K Koli, et al.. (2005). Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene. 25(18). 2588–2600. 84 indexed citations
8.
Koli, K & Jorma Keski‐Oja. (2000). 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.. PubMed. 11(4). 221–9. 114 indexed citations
9.
Arteaga, Carlos L., K Koli, Teresa C. Dugger, & Robert Clarke. (1999). Reversal of Tamoxifen Resistance of Human Breast Carcinomas In Vivo by Neutralizing Antibodies to Transforming Growth Factor- . JNCI Journal of the National Cancer Institute. 91(1). 46–53. 61 indexed citations
10.
Ko, Yong, K Koli, Sunandita S. Banerji, et al.. (1998). A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.. International Journal of Oncology. 12(1). 87–94. 12 indexed citations
11.
Koli, K & Jorma Keski‐Oja. (1996). Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation.. PubMed. 1(1). 33–8. 22 indexed citations
12.
Koli, K & Jorma Keski‐Oja. (1995). 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.. PubMed. 55(7). 1540–6. 83 indexed citations
13.
Taipale, Jussi, K Koli, & Jorma Keski‐Oja. (1992). Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin.. Journal of Biological Chemistry. 267(35). 25378–25384. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurence Vindevoghel Breakdown of academic impact, for papers by Yasutaka Hayashido Breakdown of academic impact, for papers by Anne-Christine Poncelet Breakdown of academic impact, for papers by A Ohtsuru Breakdown of academic impact, for papers by Karolina Przybyłowska Breakdown of academic impact, for papers by Kelly J. Gordon Breakdown of academic impact, for papers by William A. May Breakdown of academic impact, for papers by K. W. Schmid Breakdown of academic impact, for papers by Shanna A. Arnold Breakdown of academic impact, for papers by Óscar Busnadiego
Rankless by CCL
2026